Chronic Myeloid Leukemia (CML) Treatment Market is Projected to Grow Expeditiously: to Reach $11.32 Billion by 2029

 Created for forward-thinking professionals, this report equips teams with the insights needed to compete effectively in the chronic myeloid leukemia (cml) treatment space.

 



 How Much Is The Chronic Myeloid Leukemia (CML) Treatment Market Worth?
 The chronic myeloid leukemia (cml) treatment market size has grown strongly in recent years. It will grow from $8.23 billion in 2024 to $8.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increased awareness and early detection, clinical trial outcomes, targeted therapies development, patient advocacy and support groups, healthcare infrastructure development.
 
 The chronic myeloid leukemia (cml) treatment market size is expected to see strong growth in the next few years. It will grow to $11.32 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to personalized medicine approaches, combination therapies, increasing patient access to novel therapies, government policies supporting orphan drugs, rising healthcare expenditure. Major trends in the forecast period include global collaboration in research, telemedicine and remote monitoring, development of next-generation tkis, treatment optimization strategies.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=12084&type=smp
 
 What Are The Current Leading Growth Drivers For Chronic Myeloid Leukemia (CML) Treatment Market?
 The rising incidence and prevalence of chronic myeloid leukemia (CML) population is expected to propel the growth of the chronic myeloid leukemia (CML) treatment market going forward. Chronic myeloid leukemia, also known as chronic myelogenous leukemia, is a type of cancer that affects the bone marrow and blood. It is characterized by the overproduction of immature white blood cells called myeloid cells. Chronic myeloid leukemia (CML) treatment helps to slow the progression of cancer and stop it from reaching an advanced phase. For instance, in March 2023, according to the American Society of Clinical Oncology, a US-based professional organization representing physicians of all oncology sub-specialties, in the United States, in 2023, around 35,730 persons (19,860 men and 15,870 women) are anticipated to receive a multiple myeloma diagnosis and 12,590 deaths from this illness are anticipated in 2023 (7,000 males and 5,590 women). Therefore, the rising incidence and prevalence of chronic myeloid leukemia (CML) population is driving the growth of the chronic myeloid leukemia (CML) treatment market going forward.
 
 Which Segment Accounted For The Largest Chronic Myeloid Leukemia (CML) Treatment Market Share?
 The chronic myeloid leukemia (cml) treatmentmarket covered in this report is segmented — 
 
 1) By Type: Targeted Therapy; Chemotherapy; Radiation Therapy; Splenectomy; Stem Cell Transplant
 2) By Drug Type: Tyrosine Kinase Inhibitors; Antimetabolites; Other Drug Types
 3) By Application: Hospitals; Clinic; Other Applications
 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
 
 Subsegments:
 1) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs); Other Targeted Agents 
 2) By Chemotherapy: Combination Regimens; Single-Agent Therapies 
 3) By Radiation Therapy: Palliative Radiation; Total Body Irradiation 
 4) By Splenectomy: Laparoscopic Splenectomy; Open Splenectomy 
 5) By Stem Cell Transplant: Allogeneic Stem Cell Transplant; Autologous Stem Cell Transplant 
 
 Chronic Myeloid Leukemia (CML) Treatment Market Emerging Trends And Opportunities
 Product Innovation is a key trend gaining popularity in the chronic myeloid leukemia (CML) treatment market. Companies operating in the chronic myeloid leukemia (CML) treatment market are adopting new technologies to sustain their position in the market. For instance, in August 2022, Novartis AG, a Switzerland-based pharmaceutical company, announced the European Commission (EC) approval for Scemblix for the management of adult patients with chronic myeloid leukemia in the chronic phase (Ph+ CML-CP), which is chromosome-positive. Scemblix is the first treatment for chronic myeloid leukemia (CML) in Europe that specifically targets the ABL myristoyl pocket, a feature known as a STAMP inhibitor in scientific literature. This innovative mechanism provides a new treatment option for patients who have developed intolerance or resistance to existing tyrosine kinase inhibitors (TKIs). By reimagining the treatment approach, Scemblix addresses the needs of those who struggle with current therapies. 
 
 Which Are The Top Companies To Hold The Market Share In Chronic Myeloid Leukemia (CML) Treatment Market?
 Major companies operating in the chronic myeloid leukemia (CML) treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Incyte Corporation, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Innovent Biologics Inc., Glenmark Pharmaceuticals Limited, Il-Yang Pharmaceutical Co. Ltd., Accord Healthcare Inc., ARIAD Pharmaceuticals Inc., Orca Bio, Bio-Path Holdings Inc. 
 
 View the full chronic myeloid leukemia (cml) treatment market report here:
 https://www.thebusinessresearchcompany.com/report/chronic-myeloid-leukemia-cml-treatment-global-market-report
 
 Which Region Is Projected To Account For The Largest Share Of The Chronic Myeloid Leukemia (CML) Treatment Market?
 North America was the largest region in the chronic myeloid leukemia (CML) treatment market in 2024. The regions covered in the chronic myeloid leukemia (CML) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Global Next-Generation Advanced Batteries Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    How Is the Next-Generation Advanced Batteries Market Expected to Expand in Terms of Size and Growth?  The next-generation advanced batteries market size has grown rapidly in recent years. It will grow from $14.21 billion in 2025 to $15.93 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing adoption of electric vehicles, integration with renewable energy systems, the need for cost-effective alternatives to lithium-ion batteries, growing demand for energy storage solutions, government in...
Read more

Intense Pulsed Light (IPL) Facial Rejuvenation Device Industry Projected to Experience Accelerated Growth by 2029

Image
 Get 30% Off All Market Studies With Code ONLINE30 — Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends    What Is the Intense Pulsed Light (IPL) Facial Rejuvenation Device Market Growth Potential Across Different Regions?  The intense pulsed light (IPL) facial rejuvenation device market size has grown rapidly in recent years. It will grow from $1.05 billion in 2024 to $1.18 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to growing influence of social media beauty standards, increasing preference for youthful appearance, rising penetration of aesthetic clinics, rise in technological adoption in dermatology practices, increasing awareness of early anti-aging treatments.    The intense pulsed light (IPL) facial rejuvenation device market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate ...
Read more

Global Aggregate Stockpile Drones Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    What Is the Forecasted Market Size of the Aggregate Stockpile Drones Market by 2030?  The aggregate stockpile drones market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.20 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to growing need for accurate stockpile measurement, increasing adoption of drones in mining operations, rising focus on worker safety during surveying, expansion of quarry and aggregates production activities, growing shift from manual to ...
Read more